A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).Mikkael A. Sekeres, Kristen Sullivan, Rami S. Komrokji et al.|Blood|2009Cited by 15
Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.David L. Grinblatt, Kristen Sullivan, Mohit Narang et al.|Blood|2008Cited by 8
Transfusion Independence in Patients with Hematologic Disorders Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient RegistryDavid L. Grinblatt, Kristen Sullivan, Tim S. Dunne et al.|Blood|2008Cited by 0